NO179358C - Anvendelse av substituerte benzofuranylpiperidiner som nootropikum - Google Patents

Anvendelse av substituerte benzofuranylpiperidiner som nootropikum

Info

Publication number: NO179358C
Authority: NO; Norway
Prior art keywords: nootropics; piperidines; substituted benzofuranyl; treatment; disorders
Prior art date: 1991-02-15

Application number

NO920591A

Other languages

English (en)

Norwegian (no)

Other versions

NO920591L (no

NO920591D0 (no

NO179358B (no

Inventor

Cesare Mondadori

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-02-15

Filing date

1992-02-14

Publication date

1996-09-25

1992-02-14 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1992-02-14 Publication of NO920591D0 publication Critical patent/NO920591D0/no

1992-08-17 Publication of NO920591L publication Critical patent/NO920591L/no

1996-06-17 Publication of NO179358B publication Critical patent/NO179358B/no

1996-09-25 Publication of NO179358C publication Critical patent/NO179358C/no

Links

230000001777 nootropic effect Effects 0.000 title abstract 3
239000002664 nootropic agent Substances 0.000 title abstract 2
JVQOGYAKCWOIEK-UHFFFAOYSA-N 1-(1-benzofuran-2-yl)piperidine Chemical class C1CCCCN1C1=CC2=CC=CC=C2O1 JVQOGYAKCWOIEK-UHFFFAOYSA-N 0.000 title 1
208000012902 Nervous system disease Diseases 0.000 abstract 1
208000025966 Neurological disease Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
WZXHSWVDAYOFPE-UHFFFAOYSA-N brofaromine Chemical compound C=1C2=CC(OC)=CC(Br)=C2OC=1C1CCNCC1 WZXHSWVDAYOFPE-UHFFFAOYSA-N 0.000 abstract 1
230000007850 degeneration Effects 0.000 abstract 1
230000003412 degenerative effect Effects 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
210000002569 neuron Anatomy 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)

NO920591A 1991-02-15 1992-02-14 Anvendelse av substituerte benzofuranylpiperidiner som nootropikum NO179358C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CH47091		1991-02-15

Publications (4)

Publication Number	Publication Date
NO920591D0 NO920591D0 (no)	1992-02-14
NO920591L NO920591L (no)	1992-08-17
NO179358B NO179358B (no)	1996-06-17
NO179358C true NO179358C (no)	1996-09-25

Family

ID=4187740

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO920591A NO179358C (no)	1991-02-15	1992-02-14	Anvendelse av substituerte benzofuranylpiperidiner som nootropikum

Country Status (16)

Country	Link
EP (1)	EP0499586B1 (es)
JP (1)	JPH0570352A (es)
KR (1)	KR920016098A (es)
AT (1)	ATE138805T1 (es)
AU (1)	AU655227B2 (es)
CA (1)	CA2061015A1 (es)
DE (1)	DE59206442D1 (es)
DK (1)	DK0499586T3 (es)
ES (1)	ES2087497T3 (es)
GR (1)	GR3020155T3 (es)
IE (1)	IE74906B1 (es)
IL (1)	IL100889A (es)
MX (1)	MX9200620A (es)
NO (1)	NO179358C (es)
NZ (1)	NZ241608A (es)
ZA (1)	ZA921091B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993016696A1 (en) *	1992-02-21	1993-09-02	Ciba-Geigy Ag	Brofaromine as an agent for treating social phobia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1989003692A1 (en) *	1987-10-22	1989-05-05	Massachusetts Institute Of Technology	Treating premenstrual or late luteal phase syndrome

1992
- 1992-02-06 DE DE59206442T patent/DE59206442D1/de not_active Expired - Fee Related
- 1992-02-06 AT AT92810085T patent/ATE138805T1/de not_active IP Right Cessation
- 1992-02-06 EP EP92810085A patent/EP0499586B1/de not_active Expired - Lifetime
- 1992-02-06 DK DK92810085.8T patent/DK0499586T3/da active
- 1992-02-06 IL IL100889A patent/IL100889A/xx not_active IP Right Cessation
- 1992-02-06 ES ES92810085T patent/ES2087497T3/es not_active Expired - Lifetime
- 1992-02-10 AU AU10877/92A patent/AU655227B2/en not_active Ceased
- 1992-02-13 CA CA002061015A patent/CA2061015A1/en not_active Abandoned
- 1992-02-13 NZ NZ241608A patent/NZ241608A/en unknown
- 1992-02-13 MX MX9200620A patent/MX9200620A/es not_active IP Right Cessation
- 1992-02-13 KR KR1019920002074A patent/KR920016098A/ko not_active Abandoned
- 1992-02-14 NO NO920591A patent/NO179358C/no unknown
- 1992-02-14 ZA ZA921091A patent/ZA921091B/xx unknown
- 1992-02-14 JP JP4028252A patent/JPH0570352A/ja active Pending
- 1992-02-14 IE IE920486A patent/IE74906B1/en not_active IP Right Cessation
1996
- 1996-06-06 GR GR960401246T patent/GR3020155T3/el unknown

Also Published As

Publication number	Publication date
ATE138805T1 (de)	1996-06-15
ZA921091B (en)	1992-09-30
CA2061015A1 (en)	1992-08-16
IL100889A0 (en)	1992-11-15
EP0499586A1 (de)	1992-08-19
IE74906B1 (en)	1997-08-13
NO920591L (no)	1992-08-17
NO920591D0 (no)	1992-02-14
DK0499586T3 (da)	1996-06-24
KR920016098A (ko)	1992-09-24
AU655227B2 (en)	1994-12-08
MX9200620A (es)	1992-08-01
NZ241608A (en)	1997-06-24
ES2087497T3 (es)	1996-07-16
IL100889A (en)	1997-03-18
AU1087792A (en)	1992-08-20
DE59206442D1 (de)	1996-07-11
JPH0570352A (ja)	1993-03-23
IE920486A1 (en)	1992-08-26
EP0499586B1 (de)	1996-06-05
GR3020155T3 (en)	1996-09-30
NO179358B (no)	1996-06-17

Similar Documents

Publication	Publication Date	Title
NO931056D0 (no)	1993-03-23	Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider samt deres pyridin-n-oksider, fremgangsmaater for fremstilling derav og anvendelse av forbindelsene som legemidler
DK0574313T3 (da)	2000-04-03	1,4-disubstituerede piperaziner til behandling af sygdomme i centralnervesystemet og neuroendocrine sygdomme
NO961687L (no)	1996-06-03	Nye (R)-5-karbamoyl-8-fluor-3-N,N-disubstituerte-amino-3,4-dihydro-2H-1-benzopyraner
NO305173B1 (no)	1999-04-12	Substituerte 3-aminokinuklidiner
FI962324A0 (fi)	1996-06-03	N-substituoituja atsabisykloalkaanijohdannaisia neuroleptisinä aineina ASF
DK0633259T3 (da)	1999-09-06	Hidtil ukendte sulfonylaminopyrimidiner, fremstilling heraf og deres anvendelse som lægemidler
NO921609L (no)	1992-10-26	Sulfonamider og deres medisinske anvendelse
FI962418A0 (fi)	1996-06-11	Syklisiä amidijohdannaisia neurokiniini A antagonisteina
ATE147071T1 (de)	1997-01-15	1,4-disubstituierte piperidinderivate, ihre herstellung und therapeutische verwendung
NO941884D0 (no)	1994-05-19	1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midler
NO307029B1 (no)	2000-01-31	Anvendelse av 4-klor-5-[(4,5-dihydro-1H-imidazol-2-yl)-amino]-6-metoksy-2-metylpyrimidin til fremstilling av farmasoytiske preparater for behandling av hyperglykemier
DE69420679D1 (de)	1999-10-21	Verwendung der 1-4-4-Aryl(oder Heteroaryl)-1-Piperazinylbutyl-1H-Azol-Derivate zur Herstellung von Arzneimitteln zur Behandlung der Störungen der Magensekretion
NO881308L (no)	1988-10-10	Dihydropyridinamider, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler.
NO179358C (no)	1996-09-25	Anvendelse av substituerte benzofuranylpiperidiner som nootropikum
NO982863L (no)	1998-06-19	Nye forbindelser med analgetisk effekt
EP0535250A4 (en)	1994-09-28	Novel compounds and use thereof as medicine
PT92671A (pt)	1990-06-29	Processo para a preparacao de ariloxipropanolaminotetralinas farmaceuticamente activas
NO933521D0 (no)	1993-10-01	Acylsulfonamido- og sulfonamidopyridin-2-karboksylsyreester samt deres pyridin-n-oksyder, fremgangsmaater for deres fremstilling og deres anvendelse som legemiddel
SE8603517D0 (sv)	1986-08-20	Heterocyclic compounds and their preparation and pharmaceutical formulation
MX9405318A (es)	1995-01-31	Pirimidonas e imidazolinonas para tratamiento del choque.